Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center, Open-label, 2-period Fixed-sequence Phase I Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Pritelivir

NCT05513625 is registered in ClinicalTrials.gov with AiCuris Anti-infective Cures AG as lead sponsor.

NCT NCT05513625
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05513625 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center, Open-label, 2-period Fixed-sequence Phase I Trial to Evaluate the Effect of Esomeprazole on the Pharmacokinetics of Pritelivir
Lead sponsor
AiCuris Anti-infective Cures AG
Phase
Phase 1
Overall status
Completed
Start date
July 13, 2020
Completion date
October 13, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hsv infection